Emerging principles in protease-based drug discovery (original) (raw)

• Turk, B. Targeting proteases: successes, failures and future prospects. Nature Rev. Drug Discov. 5, 785–799 (2006).
  CAS Google Scholar
• Smith, C. G. & Vane, J. R. The discovery of captopril. FASEB J. 17, 788–789 (2003).
  CAS PubMed Google Scholar
• Flexner, C., Bate, G. & Kirkpatrick, P. Tipranavir. Nature Rev. Drug Discov. 4, 955–956 (2005).
  CAS Google Scholar
• Melnikova, I. The anticoagulants market. Nature Rev. Drug Discov. 8, 353–354 (2009).
  CAS Google Scholar
• Rawlings, N. D., Morton, F. R., Kok, C. Y., Kong, J. & Barrett, A. J. MEROPS: the peptidase database. Nucleic Acids Res. 36, D320–D325 (2008).
  CAS PubMed Google Scholar
• Timmer, J. C. et al. Structural and kinetic determinants of protease substrates. Nature Struct. Mol. Biol. 16, 1101–1108 (2009).
  CAS Google Scholar
• Davie, E. W. & Fujikawa, K. Basic mechanisms in blood coagulation. Annu. Rev. Biochem. 44, 799–829 (1975).
  CAS PubMed Google Scholar
• Davie, E. W. A brief historical review of the waterfall/cascade of blood coagulation. J. Biol. Chem. 278, 50819–50832 (2003).
  CAS PubMed Google Scholar
• Peden, J. C. Jr & Mc Farland, J. A. Use of the plasma thrombin time to assess the adequacy of in vivo neutralization of heparin: comparative studies following operations employing extracorporeal circulation. Blood 14, 1230–1236 (1959).
  PubMed Google Scholar
• Bennett, B. & Ratnoff, O. D. The normal coagulation mechanism. Med. Clin. North Am. 56, 95–104 (1972).
  CAS PubMed Google Scholar
• Turk, B., Turk, D. & Salvesen, G. S. Regulating cysteine protease activity: essential role of protease inhibitors as guardians and regulators. Curr. Pharm. Des 8, 1623–1637 (2002).
  CAS PubMed Google Scholar
• Van den Steen, P. E. et al. Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9). Crit. Rev. Biochem. Mol. Biol. 37, 375–536 (2002).
  CAS PubMed Google Scholar
• McQuibban, G. A. et al. Inflammation dampened by gelatinase A cleavage of monocyte chemoattractant protein-3. Science 289, 1202–1206 (2000).
  CAS PubMed Google Scholar
• Overall, C. M. & Dean, R. A. Degradomics: systems biology of the protease web. Pleiotropic roles of MMPs in cancer. Cancer Metastasis Rev. 25, 69–75 (2006).
  PubMed Google Scholar
• Sabeh, F., Shimizu-Hirota, R. & Weiss, S. J. Protease-dependent versus-independent cancer cell invasion programs: three-dimensional amoeboid movement revisited. J. Cell Biol. 185, 11–19 (2009).
  CAS PubMed PubMed Central Google Scholar
• Cauwe, B., Van den Steen, P. E. & Opdenakker, G. The biochemical, biological, and pathological kaleidoscope of cell surface substrates processed by matrix metalloproteinases. Crit. Rev. Biochem. Mol. Biol. 42, 113–185 (2007).
  CAS PubMed Google Scholar
• Wolf, K., Muller, R., Borgmann, S., Brocker, E. B. & Friedl, P. Amoeboid shape change and contact guidance: T-lymphocyte crawling through fibrillar collagen is independent of matrix remodeling by MMPs and other proteases. Blood 102, 3262–3269 (2003).
  CAS PubMed Google Scholar
• Uhlmann, F., Wernic, D., Poupart, M. A., Koonin, E. V. & Nasmyth, M. Cleavage of cohesin by the CD clan protease separin triggers anaphase in yeast. Cell 103, 375–386 (2000).
  CAS PubMed Google Scholar
• Kraft, C., Gmachl, M. & Peters, J. M. Methods to measure ubiquitin-dependent proteolysis mediated by the anaphase-promoting complex. Methods 38, 39–51 (2006).
  CAS PubMed Google Scholar
• Reyes-Turcu, F. E., Ventii, K. H. & Wilkinson, K. D. Regulation and cellular roles of ubiquitin-specific deubiquitinating enzymes. Annu. Rev. Biochem. 78, 363–397 (2009).
  CAS PubMed Google Scholar
• Krishnaswamy, S. Exosite-driven substrate specificity and function in coagulation. J. Thromb. Haemost. 3, 54–67 (2005).
  CAS PubMed Google Scholar
• Rijken, D. C. & Lijnen, H. R. New insights into the molecular mechanisms of the fibrinolytic system. J. Thromb. Haemost. 7, 4–13 (2009).
  CAS PubMed Google Scholar
• Hu, J., Van den Steen, P. E., Sang, Q. X. & Opdenakker, G. Matrix metalloproteinase inhibitors as therapy for inflammatory and vascular diseases. Nature Rev. Drug Discov. 6, 480–498 (2007).
  CAS Google Scholar
• Dusing, R. & Sellers, F. ACE inhibitors, angiotensin receptor blockers and direct renin inhibitors in combination: a review of their role after the ONTARGET trial. Curr. Med. Res. Opin. 25, 2287–2301 (2009).
  PubMed Google Scholar
• Maisey, H. C., Doran, K. S. & Nizet, V. Recent advances in understanding the molecular basis of group B Streptococcus virulence. Expert Rev. Mol. Med. 10, e27 (2008).
  PubMed PubMed Central Google Scholar
• Imamura, T., Potempa, J. & Travis, J. Activation of the kallikrein–kinin system and release of new kinins through alternative cleavage of kininogens by microbial and human cell proteinases. Biol. Chem. 385, 989–996 (2004).
  CAS PubMed Google Scholar
• Adams, J. & Kauffman, M. Development of the proteasome inhibitor Velcade (Bortezomib). Cancer Invest. 22, 304–311 (2004).
  CAS PubMed Google Scholar
• Green, D. R. & Evan, G. I. A matter of life and death. Cancer Cell 1, 19–30 (2002).
  CAS PubMed Google Scholar
• Mohamed, M. M. & Sloane, B. F. Cysteine cathepsins: multifunctional enzymes in cancer. Nature Rev. Cancer 6, 764–775 (2006).
  CAS Google Scholar
• Schimmer, A. D. et al. Small-molecule antagonists of apoptosis suppressor XIAP exhibit broad antitumor activity. Cancer Cell 5, 25–35 (2004).
  CAS PubMed Google Scholar
• Troy, C. M. & Salvesen, G. S. Caspases on the brain. J. Neurosci. Res. 69, 145–150 (2002).
  CAS PubMed Google Scholar
• Lopez-Otin, C. & Matrisian, L. M. Emerging roles of proteases in tumour suppression. Nature Rev. Cancer 7, 800–808 (2007).
  CAS Google Scholar
• Lu, X., Lu, D., Scully, M. & Kakkar, V. ADAM proteins — therapeutic potential in cancer. Curr. Cancer Drug Targets. 8, 720–732 (2008).
  CAS PubMed Google Scholar
• Palermo, C. & Joyce, J. A. Cysteine cathepsin proteases as pharmacological targets in cancer. Trends Pharmacol. Sci. 29, 22–28 (2008).
  CAS PubMed Google Scholar
• Mattos, C. et al. Multiple solvent crystal structures: probing binding sites, plasticity and hydration. J. Mol. Biol. 357, 1471–1482 (2006).
  CAS PubMed Google Scholar
• Kim, D. et al. (2_R_)-4-oxo-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-α]pyrazin -7(8_H_)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine: a potent, orally active dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes. J. Med. Chem. 48, 141–151 (2005).
  CAS PubMed Google Scholar
• Kim, D. et al. Discovery of potent and selective dipeptidyl peptidase IV inhibitors derived from β-aminoamides bearing subsituted triazolopiperazines. J. Med. Chem. 51, 589–602 (2008).
  CAS PubMed Google Scholar
• Leiting, B. et al. Catalytic properties and inhibition of proline-specific dipeptidyl peptidases, II, IV and VII. Biochem. J. 371, 525–532 (2003).
  CAS PubMed PubMed Central Google Scholar
• Rano, T. A. et al. A combinatorial approach for determining protease specificities: application to interleukin-1β converting enzyme (ICE). Chem. Biol. 4, 149–155 (1997).
  CAS PubMed Google Scholar
• Wood, W. J., Patterson, A. W., Tsuruoka, H., Jain, R. K. & Ellman, J. A. Substrate activity screening: a fragment-based method for the rapid identification of nonpeptidic protease inhibitors. J. Am. Chem. Soc. 127, 15521–15527 (2005).
  CAS PubMed Google Scholar
• Thompson, L. A. & Ellman, J. A. Synthesis and applications of small molecule libraries. Chem. Rev. 96, 555–600 (1996).
  CAS PubMed Google Scholar
• Schneider, E. L. & Craik, C. S. Positional scanning synthetic combinatorial libraries for substrate profiling. Methods Mol. Biol. 539, 59–78 (2009).
  CAS PubMed PubMed Central Google Scholar
• Li, J. et al. Functional profiling of recombinant NS3 proteases from all four serotypes of dengue virus using tetrapeptide and octapeptide substrate libraries. J. Biol. Chem. 280, 28766–28774 (2005).
  CAS PubMed Google Scholar
• Backes, B. J., Harris, J. L., Leonetti, F., Craik, C. S. & Ellman, J. A. Synthesis of positional-scanning libraries of fluorogenic peptide substrates to define the extended substrate specificity of plasmin and thrombin. Nature Biotechnol. 18, 187–193 (2000).
  CAS Google Scholar
• Harris, J. L. et al. Rapid and general profiling of protease specificity by using combinatorial fluorogenic substrate libraries. Proc. Natl Acad. Sci. USA 97, 7754–7759 (2000).
  CAS PubMed PubMed Central Google Scholar
• Drag, M. et al. Positional-scanning fluorigenic substrate libraries reveal unexpected specificity determinants of DUBs (deubiquitinating enzymes). Biochem. J. 415, 367–375 (2008).
  CAS PubMed Google Scholar
• Snipas, S. J., Drag, M., Stennicke, H. R. & Salvesen, G. S. Activation mechanism and substrate specificity of the Drosophila initiator caspase DRONC. Cell Death Differ. 15, 938–945 (2008).
  CAS PubMed Google Scholar
• Choe, Y. et al. Substrate profiling of cysteine proteases using a combinatorial peptide library identifies functionally unique specificities. J. Biol. Chem. 281, 12824–12832 (2006).
  CAS PubMed Google Scholar
• Brak, K., Doyle, P. S., McKerrow, J. H. & Ellman, J. A. Identification of a new class of nonpeptidic inhibitors of cruzain. J. Am. Chem. Soc. 130, 6404–6410 (2008).
  CAS PubMed PubMed Central Google Scholar
• Inagaki, H. et al. Characterization and optimization of selective, nonpeptidic inhibitors of cathepsin S with an unprecedented binding mode. J. Med. Chem. 50, 2693–2699 (2007).
  CAS PubMed Google Scholar
• Melnikova, I. Hepatitis C therapies. Nature Rev. Drug Discov. 7, 799–800 (2008).
  CAS Google Scholar
• Hu, J., Van den Steen, P. E., Dillen, C. & Opdenakker, G. Targeting neutrophil collagenase/matrix metalloproteinase-8 and gelatinase B/matrix metalloproteinase-9 with a peptidomimetic inhibitor protects against endotoxin shock. Biochem. Pharmacol. 70, 535–544 (2005).
  CAS PubMed Google Scholar
• Hu, J., Fiten, P., Van den Steen, P. E., Chaltin, P. & Opdenakker, G. Simulation of evolution-selected propeptide by high-throughput selection of a peptidomimetic inhibitor on a capillary DNA sequencer platform. Anal. Chem. 77, 2116–2124 (2005).
  CAS PubMed Google Scholar
• Piccard, H. et al. “Reverse degradomics”, monitoring of proteolytic trimming by multi-CE and confocal detection of fluorescent substrates and reaction products. Electrophoresis 30, 2366–2377 (2009).
  CAS PubMed Google Scholar
• Turk, B. E., Huang, L. L., Piro, E. T. & Cantley, L. C. Determination of protease cleavage site motifs using mixture-based oriented peptide libraries. Nature Biotechnol. 19, 661–667 (2001).
  CAS Google Scholar
• Turk, B. E. et al. MMP-20 is predominately a tooth-specific enzyme with a deep catalytic pocket that hydrolyzes type V collagen. Biochemistry 45, 3863–3874 (2006).
  CAS PubMed Google Scholar
• Turk, B. E. et al. The structural basis for substrate and inhibitor selectivity of the anthrax lethal factor. Nature Struct. Mol. Biol. 11, 60–66 (2004).
  CAS Google Scholar
• Watzke, A. et al. Selective activity-based probes for cysteine cathepsins. Angew. Chem. Int. Edn Engl. 47, 406–409 (2008).
  CAS Google Scholar
• Matthews, D. J. & Wells, J. A. Substrate phage: selection of protease substrates by monovalent phage display. Science 260, 1113–1117 (1993).
  CAS PubMed Google Scholar
• Hansen, M. et al. A urokinase-type plasminogen activator-inhibiting cyclic peptide with an unusual P2 residue and an extended protease binding surface demonstrates new modalities for enzyme inhibition. J. Biol. Chem. 280, 38424–38437 (2005).
  CAS PubMed Google Scholar
• Scholle, M. D. et al. Mapping protease substrates by using a biotinylated phage substrate library. Chembiochem 7, 834–838 (2006).
  CAS PubMed Google Scholar
• Timmer, J. C. & Salvesen, G. S. Caspase substrates. Cell Death Differ. 14, 66–72 (2007).
  CAS PubMed Google Scholar
• Impens, F. et al. MS-driven protease substrate degradomics. Proteomics 10, 1284–1296 (2010).
  CAS PubMed Google Scholar
• Chen, X. et al. Inhibitors of Plasmodium falciparum methionine aminopeptidase 1b possess antimalarial activity. Proc. Natl Acad. Sci. USA 103, 14548–14553 (2006).
  CAS PubMed PubMed Central Google Scholar
• Pellecchia, M. et al. Perspectives on NMR in drug discovery: a technique comes of age. Nature Rev. Drug Discov. 7, 738–745 (2008).
  CAS Google Scholar
• Erlanson, D. A. et al. In situ assembly of enzyme inhibitors using extended tethering. Nature Biotechnol. 21, 308–314 (2003).
  CAS Google Scholar
• Eckelman, B. P., Salvesen, G. S. & Scott, F. L. Human inhibitor of apoptosis proteins: why XIAP is the black sheep of the family. EMBO Rep. 7, 988–994 (2006).
  CAS PubMed PubMed Central Google Scholar
• Rydel, T. J. et al. The structure of a complex of recombinant hirudin and human α-thrombin. Science 249, 277–280 (1990).
  CAS PubMed Google Scholar
• Wada, C. K. The evolution of the matrix metalloproteinase inhibitor drug discovery program at Abbott laboratories. Curr. Top. Med. Chem. 4, 1255–1267 (2004).
  CAS PubMed Google Scholar
• Wang, J. et al. Tumor suppression by a rationally designed reversible inhibitor of methionine aminopeptidase-2. Cancer Res. 63, 7861–7869 (2003).
  CAS PubMed Google Scholar
• Forino, M. et al. Efficient synthetic inhibitors of anthrax lethal factor. Proc. Natl Acad. Sci. USA 102, 9499–9504 (2005).
  CAS PubMed PubMed Central Google Scholar
• Hardy, J. A., Lam, J., Nguyen, J. T., O'Brien, T. & Wells, J. A. Discovery of an allosteric site in the caspases. Proc. Natl Acad. Sci. USA 101, 12461–12466 (2004).
  CAS PubMed PubMed Central Google Scholar
• Herman, G. A., Stein, P. P., Thornberry, N. A. & Wagner, J. A. Dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes: focus on sitagliptin. Clin. Pharmacol. Ther. 81, 761–767 (2007).
  CAS PubMed Google Scholar
• McKerrow, J. H., Engel, J. C. & Caffrey, C. R. Cysteine protease inhibitors as chemotherapy for parasitic infections. Bioorg Med. Chem. 7, 639–644 (1999).
  CAS PubMed Google Scholar
• Renatus, M. et al. Structural basis of ubiquitin recognition by the deubiquitinating protease USP2. Structure 14, 1293–1302 (2006).
  CAS PubMed PubMed Central Google Scholar
• Mikolajczyk, J. et al. Small ubiquitin-related modifier (SUMO)-specific proteases: profiling the specificities and activities of human SENPs. J. Biol. Chem. 282, 26217–26224 (2007).
  CAS PubMed Google Scholar
• Drag, M., Mikolajczyk, J., Krishnakumar, I. M., Huang, Z. & Salvesen, G. S. Activity profiling of human deSUMOylating enzymes (SENPs) with synthetic substrates suggests an unexpected specificity of two newly characterized members of the family. Biochem. J. 409, 461–469 (2008).
  CAS PubMed Google Scholar
• Reyes-Turcu, F. E. et al. The ubiquitin binding domain ZnF UBP recognizes the C-terminal diglycine motif of unanchored ubiquitin. Cell 124, 1197–1208 (2006).
  CAS PubMed Google Scholar
• Kornacker, M. G. et al. An inhibitor binding pocket distinct from the catalytic active site on human β-APP cleaving enzyme. Biochemistry 44, 11567–11573 (2005).
  CAS PubMed Google Scholar
• Shahian, T. et al. Inhibition of a viral enzyme by a small-molecule dimer disruptor. Nat. Chem. Biol. 5, 640–646 (2009).
  CAS PubMed PubMed Central Google Scholar
• Schweizer, A. et al. Inhibition of caspase-2 by a designed ankyrin repeat protein: specificity, structure, and inhibition mechanism. Structure 15, 625–636 (2007).
  CAS PubMed Google Scholar
• Thornberry, N. A. et al. A combinatorial approach defines specificities of members of the caspase family and granzyme B. Functional relationships established for key mediators of apoptosis. J. Biol. Chem. 272, 17907–17911 (1997).
  CAS PubMed Google Scholar
• Silverman, G. A. et al. The serpins are an expanding superfamily of structurally similar but funtionally diverse proteins: evolution, mechanism of inhibition, novel functions, and a revised nomenclature. J. Biol. Chem. 276, 33293–33296 (2001).
  CAS PubMed Google Scholar
• Brennan, S. Revisiting α1-antitrypsin therapy in cystic fibrosis: can it still offer promise? Eur. Respir. J. 29, 229–230 (2007).
  CAS PubMed Google Scholar
• Stoop, A. A. & Craik, C. S. Engineering of a macromolecular scaffold to develop specific protease inhibitors. Nature Biotechnol. 21, 1063–1068 (2003).
  CAS Google Scholar
• Dennis, M. S., Herzka, A. & Lazarus, R. A. Potent and selective Kunitz domain inhibitors of plasma kallikrein designed by phage display. J. Biol. Chem. 270, 25411–25417 (1995).
  CAS PubMed Google Scholar
• Levy, J. H. & O'Donnell, P. S. The therapeutic potential of a kallikrein inhibitor for treating hereditary angioedema. Expert Opin. Investig. Drugs 15, 1077–1090 (2006).
  CAS PubMed Google Scholar
• Xuan, J. A. et al. Antibodies neutralizing hepsin protease activity do not impact cell growth but inhibit invasion of prostate and ovarian tumor cells in culture. Cancer Res. 66, 3611–3619 (2006).
  CAS PubMed Google Scholar
• Sun, J., Pons, J. & Craik, C. S. Potent and selective inhibition of membrane-type serine protease 1 by human single-chain antibodies. Biochemistry 42, 892–900 (2003).
  CAS PubMed Google Scholar
• Devy, L. et al. Selective inhibition of matrix metalloproteinase-14 blocks tumor growth, invasion, and angiogenesis. Cancer Res. 69, 1517–1526 (2009).
  CAS PubMed Google Scholar
• Lazarus, R. A., Olivero, A. G., Eigenbrot, C. & Kirchhofer, D. Inhibitors of tissue factor. Factor VIIa for anticoagulant therapy. Curr. Med. Chem. 11, 2275–2290 (2004).
  CAS PubMed Google Scholar
• Chang, M.W. et al. Identification of broad-based HIV-1 protease inhibitors from combinatorial libraries. Biochem J. 429, 527–532 (2010).
  CAS PubMed Google Scholar
• Brenke, R. et al. Fragment-based identification of druggable 'hot spots' of proteins using Fourier domain correlation techniques. Bioinformatics 25, 621–627 (2009).
  CAS PubMed PubMed Central Google Scholar
• Bogoyevitch, M. A. & Fairlie, D. P. A new paradigm for protein kinase inhibition: blocking phosphorylation without directly targeting ATP binding. Drug Discov. Today 12, 622–633 (2007).
  CAS PubMed Google Scholar
• Conn, P. J., Christopoulos, A. & Lindsley, C. W. Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disorders. Nature Rev. Drug Discov. 8, 41–54 (2009).
  CAS Google Scholar
• Goodey, N. M. & Benkovic, S. J. Allosteric regulation and catalysis emerge via a common route. Nat. Chem. Biol. 4, 474–482 (2008).
  CAS PubMed Google Scholar
• Falati, S., Gross, P., Merrill-Skoloff, G., Furie, B. C. & Furie, B. Real-time in vivo imaging of platelets, tissue factor and fibrin during arterial thrombus formation in the mouse. Nature Med. 8, 1175–1181 (2002).
  CAS PubMed Google Scholar
• Girolami, A., Randi, M. L., Gavasso, S., Lombardi, A. M. & Spiezia, F. The occasional venous thromboses seen in patients with severe (homozygous) FXII deficiency are probably due to associated risk factors: a study of prevalence in 21 patients and review of the literature. J. Thromb. Thrombolysis 17, 139–143 (2004).
  CAS PubMed Google Scholar
• Baglia, F. A. & Walsh, P. N. Thrombin-mediated feedback activation of factor XI on the activated platelet surface is preferred over contact activation by factor XIIa or factor XIa. J. Biol. Chem. 275, 20514–20519 (2000).
  CAS PubMed Google Scholar
• Renné, T. & Gailani, D. Role of factor XII in hemostasis and thrombosis: clinical implications. Expert Rev. Cardiovasc. Ther. 5, 733–741 (2007).
  PubMed Google Scholar
• Duncan, R. C., Wijeyewickrema, L. C. & Pike, R. N. The initiating proteases of the complement system: controlling the cleavage. Biochimie 90, 387–395 (2008).
  CAS PubMed Google Scholar
• Fuentes-Prior, P. & Salvesen, G. S. The protein structures that shape caspase activity, specificity, activation and inhibition. Biochem. J. 384, 201–232 (2004).
  CAS PubMed PubMed Central Google Scholar
• Wilson, N. S., Dixit, V. & Ashkenazi, A. Death receptor signal transducers: nodes of coordination in immune signaling networks. Nature Immunol. 10, 348–355 (2009).
  CAS Google Scholar
• Riedl, S. J. & Salvesen, G. S. The apoptosome: signalling platform of cell death. Nature Rev. Mol. Cell Biol. 5, 405–413 (2007).
  Google Scholar
• LeMosy, E. K., Tan, Y. Q. & Hashimoto, C. Activation of a protease cascade involved in patterning the Drosophila embryo. Proc. Natl Acad. Sci. USA 98, 5055–5060 (2001).
  CAS PubMed PubMed Central Google Scholar
• Coussens, L. M., Fingleton, B. & Matrisian, L. M. Matrix metalloproteinase inhibitors and cancer: trials and tribulations. Science 295, 2387–2392 (2002).
  CAS PubMed Google Scholar
• Overall, C. M. & Kleifeld, O. Towards third generation matrix metalloproteinase inhibitors for cancer therapy. Br. J. Cancer 94, 941–946 (2006).
  CAS PubMed PubMed Central Google Scholar
• Jensen, C., Herold, P. & Brunner, H. R. Aliskiren: the first renin inhibitor for clinical treatment. Nature Rev. Drug Discov. 7, 399–410 (2008).
  CAS Google Scholar
• Szelke, M. et al. Potent new inhibitors of human renin. Nature 299, 555–557 (1982).
  CAS PubMed Google Scholar
• Clozel, J. P. & Fischli, W. Discovery of remikiren as the first orally active renin inhibitor. Arzneimittelforschung 43, 260–262 (1993).
  CAS PubMed Google Scholar
• Sureshkumar, K. K. Renin inhibition with aliskiren in hypertension: focus on aliskiren/hydrochlorothiazide combination therapy. Vasc. Health Risk Manag. 4, 1205–1220 (2008).
  CAS PubMed PubMed Central Google Scholar
• Thornberry, N. A. & Weber, A. E. Discovery of Januvia (sitagliptin), a selective dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes. Curr. Top. Med. Chem. 7, 557–568 (2007).
  CAS PubMed Google Scholar
• Weber, A. E. Dipeptidyl peptidase IV inhibitors for the treatment of diabetes. J. Med. Chem. 47, 4135–4141 (2004).
  CAS PubMed Google Scholar
• Liu, Y. et al. Discovery of inhibitors that elucidate the role of UCH-L1 activity in the H1299 lung cancer cell line. Chem. Biol. 10, 837–846 (2003).
  CAS PubMed Google Scholar
• Stack, C. M. et al. Characterization of the Plasmodium falciparum M17 leucyl aminopeptidase. A protease involved in amino acid regulation with potential for antimalarial drug development. J. Biol. Chem. 282, 2069–2080 (2007).
  CAS PubMed Google Scholar
• Cunningham, E., Drag, M., Kafarski, P. & Bell, A. Chemical target validation studies of aminopeptidase in malaria parasites using α-aminoalkylphosphonate and phosphonopeptide inhibitors. Antimicrob. Agents Chemother. 52, 3221–3228 (2008).
  CAS PubMed PubMed Central Google Scholar
• Maric, S. et al. The M17 leucine aminopeptidase of the malaria parasite Plasmodium falciparum: the importance of active site metal ions in the binding of substrates and inhibitors. Biochemistry 48, 5435–5439 (2009).
  CAS PubMed Google Scholar
• Skinner-Adams, T. S. et al. Identification of phosphinate dipeptide analog inhibitors directed against the Plasmodium falciparum M17 leucine aminopeptidase as lead antimalarial compounds. J. Med. Chem. 50, 6024–6031 (2007).
  CAS PubMed Google Scholar
• Kuebler, P. S. Method of treating stroke with thrombolytic agent. US patent 20080107641 (2007).
• Rojkjaer, R. G. ). Pharmaceutical composition comprising factor VII polypeptides and TAFI polypeptides. US patent 20030118574 (2002).
• Varadarajan, N., Georgiou, G. & Iverson, B. L. An engineered protease that cleaves specifically after sulfated tyrosine. Angew. Chem. Int. Ed Engl. 47, 7861–7863 (2008).
  CAS PubMed PubMed Central Google Scholar
• Varadarajan, N., Rodriguez, S., Hwang, B. Y., Georgiou, G. & Iverson, B. L. Highly active and selective endopeptidases with programmed substrate specificities. Nature Chem. Biol. 4, 290–294 (2008).
  CAS Google Scholar
• Madison, E. L., Thanos, C., Ruggles, S. W. & Coughlin, S. Modified factor VII polypeptides and uses thereof. US patent 20090098103 (2008).
• Tanaka, F. Catalytic antibodies as designer proteases and esterases. Chem. Rev. 102, 4885–4906 (2002).
  CAS PubMed Google Scholar
• Reverter, D. & Lima, C. D. A basis for SUMO protease specificity provided by analysis of human Senp2 and a Senp2–SUMO complex. Structure 12, 1519–1531 (2004).
  CAS PubMed Google Scholar
• Friedrich, R., Steinmetzer, T., Huber, R., Sturzebecher, J. & Bode, W. The methyl group of Nα(Me)Arg-containing peptides disturbs the active-site geometry of thrombin, impairing efficient cleavage. J. Mol. Biol. 316, 869–874 (2002).
  CAS PubMed Google Scholar
• Lupardus, P. J., Shen, A., Bogyo, M. & Garcia, K. C. Small molecule-induced allosteric activation of the Vibrio cholerae RTX cysteine protease domain. Science 322, 265–268 (2008).
  CAS PubMed PubMed Central Google Scholar
• Schecter, I. & Berger, M. On the size of the active site in proteases. Biochem. Biophys. Res. Commun. 27, 157–162 (1967).
  Google Scholar
• Matheson, A.J. & Goa, K.L. Desirudin: a review of its use in the management of thrombotic disorders. Drugs 60, 679–700 (2000).
  CAS PubMed Google Scholar
• Kakar, P., Watson, T. & Lip, G.Y. Drug evaluation: rivaroxaban, an oral, direct inhibitor of activated factor X. Curr. Opin. Investig. Drugs 8, 256–265 (2007).
  CAS PubMed Google Scholar
• Eriksson, B.I., Smith, H., Yasothan, U. & Kirkpatrick, P. Dabigatran etexilate. Nature Rev. Drug Discov. 7, 557–558 (2008).
  CAS Google Scholar
• Matsuo, T., Koide, M. & Kario, K. Development of argatroban, a direct thrombin inhibitor, and its clinical application. Semin. Thromb. Hemost. 23, 517–522 (1997).
  CAS PubMed Google Scholar